A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Study Medicine On Peripheral Nerve Function In Patients With Osteoarthritis
-
- STATUS
- Recruiting
Summary
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Study Medicine On Peripheral Nerve Function In Patients With Osteoarthritis
Description
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Of Study Medicine On Peripheral Nerve Function In Patients With Osteoarthritis
Patient Inclusion Criteria:
- BMI less or equal to 39 kg/m2
- Osteoarthritis (arthritis) of the knee or hip with pain score that qualifies
Patient Exclusion Criteria:
- Untreated, uncontrolled diseases,
- Unwilling or unable to discontinue the use of prohibited medications, including other pain medications, during the screening period and during the study,
- Significant cardiac disease within the past 6 months
- Significant neurological disease
- Known bleeding disorder or anticoagulation therapy
- Planned surgery during the study period
- History of alcoholism or drug abuse in the past 2 years
- Unable to use acetaminophen
- Use of a biologic (including live vaccines, with the exception of Flumist) within the past 3 months
- Allergic reaction to a biologic or an antibody in the past
- Disqualifying laboratory values, including Hepatitis B or C, HIV or drug test
- Cancer in the past 5 years. Basal cell or squamous cell carcinoma are okay.
Details
| Condition | Osteoarthritis |
|---|---|
| Clinical Study Identifier | TX134905 |
| Last Modified on | 8 November 2020 |
Eligibility
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer